Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.50 CNY
279.77 M CNY
1.36 B CNY
287.94 M
About GETEIN BIOTECH, INC.
Sector
Industry
CEO
En Ben Su
Website
Headquarters
Nanjing
Founded
2002
ISIN
CNE100002RR9
FIGI
BBG00BGK14Y6
Getein Biotech, Inc. engages in the business of medical health industry chain. It focuses on the development, production, sales and service of in vitro diagnostic products. Its products include diagnostic reagent; diagnostic analyzer; calibrator; quality control such as cardiac markers, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus; and raw material such as antigen, monoclonal antibody, polyclonal antibody, antiserum, and microsphere. The company was founded by En Ben Su on March 8, 2002 and is headquartered in Nanjing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603387 is 8.79 CNY — it has decreased by −3.51% in the past 24 hours. Watch GETEIN BIOTECH, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GETEIN BIOTECH, INC. stocks are traded under the ticker 603387.
603387 stock has risen by 1.97% compared to the previous week, the month change is a 5.02% rise, over the last year GETEIN BIOTECH, INC. has showed a −25.00% decrease.
603387 reached its all-time high on Jul 10, 2020 with the price of 23.69 CNY, and its all-time low was 6.93 CNY and was reached on Sep 23, 2024. View more price dynamics on 603387 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603387 stock is 4.34% volatile and has beta coefficient of 1.34. Track GETEIN BIOTECH, INC. stock price on the chart and check out the list of the most volatile stocks — is GETEIN BIOTECH, INC. there?
Today GETEIN BIOTECH, INC. has the market capitalization of 4.46 B, it has increased by 5.81% over the last week.
Yes, you can track GETEIN BIOTECH, INC. financials in yearly and quarterly reports right on TradingView.
GETEIN BIOTECH, INC. is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
603387 net income for the last quarter is 55.48 M CNY, while the quarter before that showed 60.80 M CNY of net income which accounts for −8.75% change. Track more GETEIN BIOTECH, INC. financial stats to get the full picture.
GETEIN BIOTECH, INC. dividend yield was 1.82% in 2023, and payout ratio reached 36.26%. The year before the numbers were 2.40% and 30.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has 2.14 K employees. See our rating of the largest employees — is GETEIN BIOTECH, INC. on this list?
Like other stocks, 603387 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GETEIN BIOTECH, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GETEIN BIOTECH, INC. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GETEIN BIOTECH, INC. stock shows the sell signal. See more of GETEIN BIOTECH, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.